|The TTR ttr (Catalog #MBS151877) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Transthyretin can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).
Transthyretin peptide is used for blocking the activity of Transthyretin antibody. Researchers should empirically determine the suitability of the TTR ttr for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TTR ttr product has the following accession number(s) (GI #136464) (NCBI Accession #P02766.1) (Uniprot Accession #P02766). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 17 amino acids near the center of human Transthyretin. The following patways have been known to be associated with this gene. TTR also interacts with the following gene(s): APCS, APOA1, APP, CST3, FOXA3, RBP4, SERPINA7. Amyloid Neuropathies, Familial, Amyloidosis, Familial, Brain Diseases, Carcinoma, Hepatocellular, Cardiovascular Diseases, Heart Diseases, Inflammation, Liver Diseases, Liver Neoplasms, Nervous System Diseases are some of the diseases may be linked to Transthyretin Peptide. Brain, Embryonic Tissue, Eye, Heart, Kidney, Liver, Lung, Muscle, Pancreas, Skin tissues are correlated with this protein.